DK121080A - Fremgangsmaade til fremstilling af 2-piperazinoquinazolinderivater - Google Patents

Fremgangsmaade til fremstilling af 2-piperazinoquinazolinderivater

Info

Publication number
DK121080A
DK121080A DK121080A DK121080A DK121080A DK 121080 A DK121080 A DK 121080A DK 121080 A DK121080 A DK 121080A DK 121080 A DK121080 A DK 121080A DK 121080 A DK121080 A DK 121080A
Authority
DK
Denmark
Prior art keywords
piperazinoquinazoline
derivatives
preparing
procedure
piperazinoquinazoline derivatives
Prior art date
Application number
DK121080A
Other languages
Danish (da)
English (en)
Inventor
S F Campbell
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10504770&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK121080(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer filed Critical Pfizer
Publication of DK121080A publication Critical patent/DK121080A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK121080A 1979-04-25 1980-03-20 Fremgangsmaade til fremstilling af 2-piperazinoquinazolinderivater DK121080A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7914431 1979-04-25

Publications (1)

Publication Number Publication Date
DK121080A true DK121080A (da) 1980-10-26

Family

ID=10504770

Family Applications (1)

Application Number Title Priority Date Filing Date
DK121080A DK121080A (da) 1979-04-25 1980-03-20 Fremgangsmaade til fremstilling af 2-piperazinoquinazolinderivater

Country Status (33)

Country Link
US (1) US4279910A (fi)
JP (1) JPS55145684A (fi)
KR (1) KR830002567B1 (fi)
AR (1) AR224400A1 (fi)
AT (1) AT373596B (fi)
BE (1) BE882967A (fi)
CA (1) CA1132558A (fi)
CH (1) CH642076A5 (fi)
CS (1) CS209950B2 (fi)
DD (1) DD150202A5 (fi)
DE (1) DE3015676A1 (fi)
DK (1) DK121080A (fi)
EG (1) EG14651A (fi)
ES (1) ES8101588A1 (fi)
FI (1) FI64592C (fi)
FR (1) FR2455042A1 (fi)
GB (1) GB2049683B (fi)
GR (1) GR68049B (fi)
HU (1) HU184747B (fi)
IE (1) IE49705B1 (fi)
IL (1) IL59900A (fi)
IT (1) IT1141490B (fi)
LU (1) LU82394A1 (fi)
NL (1) NL182563C (fi)
NO (1) NO152508C (fi)
NZ (1) NZ193511A (fi)
PH (1) PH15156A (fi)
PL (1) PL121470B1 (fi)
PT (1) PT71139A (fi)
SE (1) SE435061B (fi)
SU (1) SU915804A3 (fi)
YU (1) YU41709B (fi)
ZA (1) ZA802488B (fi)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3511836A (en) * 1967-12-13 1970-05-12 Pfizer & Co C 2,4,6,7-tetra substituted quinazolines
US3663706A (en) * 1969-09-29 1972-05-16 Pfizer Use of 2,4-diaminoquinazolines as hypotensive agents
US4026894A (en) * 1975-10-14 1977-05-31 Abbott Laboratories Antihypertensive agents
US4001237A (en) * 1976-02-18 1977-01-04 Bristol-Myers Company Oxazole, isoxazole, thiazole and isothiazole amides
US4140776A (en) * 1977-09-16 1979-02-20 Merck & Co., Inc. N-pyrazinecarbonyl-N'-acylguanidines
GB2007656B (en) * 1977-11-05 1982-05-19 Pfizer Ltd Therapeutic agents

Also Published As

Publication number Publication date
FI64592B (fi) 1983-08-31
NO152508B (no) 1985-07-01
YU113180A (en) 1983-02-28
SU915804A3 (en) 1982-03-23
CA1132558A (en) 1982-09-28
FR2455042A1 (fr) 1980-11-21
NL182563C (nl) 1988-04-05
PL121470B1 (en) 1982-05-31
IE800827L (en) 1980-10-25
GB2049683A (en) 1980-12-31
US4279910A (en) 1981-07-21
KR830002567B1 (ko) 1983-11-14
NO152508C (no) 1985-10-09
ATA218980A (de) 1983-06-15
GB2049683B (en) 1983-01-26
IL59900A (en) 1983-11-30
EG14651A (en) 1985-03-31
DD150202A5 (de) 1981-08-19
DE3015676A1 (de) 1980-11-13
AR224400A1 (es) 1981-11-30
PL223755A1 (fi) 1981-02-13
BE882967A (fr) 1980-10-24
IT1141490B (it) 1986-10-01
FI801306A (fi) 1980-10-26
CH642076A5 (de) 1984-03-30
ES490867A0 (es) 1980-12-16
FR2455042B1 (fi) 1983-05-20
IE49705B1 (en) 1985-11-27
HU184747B (en) 1984-10-29
NL8002387A (nl) 1980-10-28
NZ193511A (en) 1982-03-30
GR68049B (fi) 1981-10-29
SE8003122L (sv) 1980-10-26
NL182563B (nl) 1987-11-02
AT373596B (de) 1984-02-10
LU82394A1 (fr) 1980-07-31
JPS55145684A (en) 1980-11-13
PH15156A (en) 1982-08-24
PT71139A (en) 1980-05-01
ES8101588A1 (es) 1980-12-16
YU41709B (en) 1987-12-31
CS209950B2 (en) 1981-12-31
NO801196L (no) 1980-10-27
IL59900A0 (en) 1980-06-30
SE435061B (sv) 1984-09-03
FI64592C (fi) 1983-12-12
ZA802488B (en) 1981-08-26
JPS5738591B2 (fi) 1982-08-16
IT8021598A0 (it) 1980-04-23
KR830002758A (ko) 1983-06-30

Similar Documents

Publication Publication Date Title
DK157019C (da) Analogifremgangsmaade til fremstilling af 2-amino-4-hydroxyquinazolinderivater
DK363179A (da) Fremgangsmaade til fremstilling af tetrazolylalkoxycarbostyrilderivater
DK457779A (da) Fremgangsmaade til fremstilling af 4-hydroxy-2-pyronderivater
DK147225C (da) Fremgangsmaade til fremstilling af intravenoest indgivelige immunogammaglobulinderivater
DK468880A (da) Fremgangsmaade til fremstilling af enzymderivater
DK488379A (da) Fremgangsmaade til fremstilling af polyetherderivater
DK539578A (da) Fremgangsmaade til fremstilling af pleuromutilinglycsid-derivater
DK294880A (da) Fremgangsmaade til fremstilling af n-phosphonomethylglycin
DK531178A (da) Fremgangsmaade til fremstilling af phenylglycinderivater
DK413780A (da) Fremgangsmaade til fremstilling af d-6-n-propylergoliner
DK54280A (da) Fremgangsmaade til fremstilling af heterotricykliske derivater
DK316480A (da) Fremgangsmaade til fremstilling af pyridazinderivater
DK396880A (da) Fremgangsmaade til fremstilling af cyclohexancarboxylsyrederivater
DK138879A (da) Fremgangsmaade til fremstilling af lysergolderivater
DK470978A (da) R fremgangsmaade til fremstilling af pyrazinobenzoxapinderivate
DK205580A (da) Fremgangsmaade til fremstilling af benzodiazepinderivater
DK152130C (da) Fremgangsmaade til fremstilling af benzooebaathienopyridinderivater
DK494978A (da) Fremgangsmaade til fremstilling af 2-iminoimidazolidinderivater
DK177680A (da) Fremgangsmaade til fremstilling af 7-n-heterocyclyl-cephalosporiner
DK395880A (da) Fremgangsmaade til fremstilling af pyridazinderivater
DK134880A (da) Fremgangsmaade til fremstilling af benzothiazolderivater fremgangsmaade til fe
DK157850C (da) Fremgangsmaade til fremstilling af 7-acylindolin-2-oner
DK520178A (da) Fremgangsmaade til fremstilling af phenoxyalkanolamin-derivater
DK392879A (da) Fremgangsmaade til fremstilling af 3-karbamouloxymetylcephalosorinforbindelser
DK183780A (da) Femgangsmaade til fremstilling af hydroxyderivater af isopropylaminopyrimidin

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment
PBP Patent lapsed